LNP Characterization and Analytical Development on November 18-19, 2026 in Boston, United States

As LNP systems become more sophisticated and RNA therapeutics move toward targeted delivery, multi-cargo constructs, and increasingly complex modalities, the demands on characterization and analytical development have never been greater.

Traditional approaches are no longer sufficient to define product quality, understand structure-function relationships, or meet evolving regulatory expectations.

The 4th LNP Characterization and Analytical Development Summit is the only dedicated forum focused exclusively on solving the analytical and characterization challenges shaping the future of LNP-enabled medicines.

Join analytical development, characterization, formulation, and CMC leaders from across pharma and biotech to uncover the latest advances in predictive CQAs, structural characterization, targeted LNP analytics, multi-attribute methods, and strategies for complex payload systems. Through technical case studies, interactive discussions, poster presentations, and high-value networking, gain practical insight into how the industry is accelerating development while reducing risk.

As innovation in RNA medicines continues to outpace analytical standards, this is the critical meeting point to benchmark approaches, shape future best practice, and stay ahead of the next generation of LNP development.

URLs:

Website: https://go.evvnt.com/3721321-0?pid=10008

Tickets: https://go.evvnt.com/3721321-2?pid=10008

Brochure: https://go.evvnt.com/3721321-3?pid=10008

Prices:

Drug Developer Pricing - 2 Day Conference: USD 3099.00,

Academic Pricing - 2 Day Conference: USD 2699.00,

Service Provider Pricing - 2 Day Conference: USD 3799.00

Speakers: Vinu Krishnan Principal Scientist, Research Formulation Development, Advanced Drug Delivery, CMC R and D, Abbvie, Yuchen Fan Principal Scientist, Genentech, Marco Blanco, Principal Scientist, Merck and Co, Elias Halabi, Senior Scientist, Non-Viral Delivery, Novo Nordisk, Long Zhang, Principal Scientist, Genomic Medicine Unit Analytical Development, Sanofi, Zhang Xiaobin, Associate Director, Takeda Pharmaceutical, Justin Fang, Senior Scientist, Amplitude Therapeutics, Zack Zhang, Senior Director, Analytical Research and Development, Beam Therapeutics, Ghloan-Martin Hamraz, Ex-BioNTech, BioNTech, Rammohan Devulapally, Senior Director, Head of Non-Viral Delivery, Granza Bio, Chi Zhang, Co-Founder, GT Biosciences, Russell Johnson, Executive Director, Independent Expert, Hui Zhou, Principal Scientist, ModeX Therapeutics, Meredith Packer, Director, Analytical Development, Nava Therapeutics, Jian Jiang, Senior Scientist, Prime Medicine, Pintu Kanjilal, Scientist, LNP Discovery, Strand Therapeutics, Kyle Bake, Principal Scientist, Chemistry, Manufacturing, Controls, Analytical Development, Stylus Medicine, Chris Geisert, Senior Associate Scientist, Stylus Medicine, Mohit Gupta, Principal Scientist, Tessera Therapeutics

Category: Conferences | Science, Health and Medicine | Pharmaceuticals

Date and Time: 18th November 2026 at 8:00 am to 19th November 2026 at 6:00 pm